You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Bexsero packshot

Product overview

Indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B

Order now

Support materials

A Bexsero administration guide and parent communication checklist to support you and your practice.

Is there a need for meningitis B private vaccination?

GSK has created a series of short videos exploring the burden of the disease, at risk group and in depth look at GSK meningitis B vaccine, Bexsero.

Meningitis B - epidemiology, signs and symptoms.

Who are the patients at risk in the UK?

Overview of Bexsero.

Bexsero is a registered trademark of the GlaxoSmithKline group of companies.